Polar Capital Holdings »

Bridgebio Pharma shares owned by Polar Capital Holdings

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Polar Capital Holdings from 13F filings

Historical chart of Polar Capital Holdings investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Polar Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Polar Capital Holdings

Quarter filed Position value Share count Share price at filing
2025-09-30 $51M 981k 51.94

More positions owned by Polar Capital Holdings

NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Microsoft Corporation Call Option (MSFT)
Cloudflare Cl A Com (NET)
Lam Research Corp Com New (LRCX)
Kla Corp Com New (KLAC)
Seagate Technology Hldngs Pl Ord Shs (STX)
Renaissance Re Holdings Ltd Cmn (RNR)
Apple (AAPL)
Corning Incorporated (GLW)
Arch Cap Group Ord (ACGL)
Micron Technology (MU)
Advanced Micro Devices (AMD)
Credo Technology Group Holdi Ordinary Shares (CRDO)

View all positions for Polar Capital Holdings

Top funds holding Bridgebio Pharma

Vanguard Group
Viking Global Investors
BlackRock
Kohlberg Kravis Roberts & Co
Henderson Group
Farallon Capital Management
UBS Group
Aisling Capital Management
State Street Corporation
Jane Street
Susquehanna International
Invesco
Geode Capital Management
Frazier Life Sciences Management
Two Sigma Investments

View all funds holding Bridgebio Pharma